Vitamin D Bone Density Meta-analysis: What the Evidence Says

Quick Answer

Vitamin D Bone Density Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 observational study, 1 research article.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• High-quality meta-analyses of randomized clinical trials (RCT) found that vitamin D supplementation would help increase the BMD in the femur neck area but not at other sites (Reid et al. ). [Zeng Hualian (2026); evidence level 3]
• Furthermore, large-scale trials, such as the VITAL trial, have demonstrated that supplemental vitamin D3 (2000 IU/day) did not result in significant bone density changes compared to placebo at the spine, hip, or total body in generally healthy adults (LeBoff et al. ). [Zeng Hualian (2026); evidence level 3]
• Aging amplifies the risk of vitamin D inadequacy through reduced cutaneous synthesis, impaired renal and hepatic activation, and diminished sun exposure. [Li Yupeng (2026); evidence level 4]
• A recent global meta-analysis found that approximately 59.7% (95% CI 45.9-72.1) of elderly individuals are vitamin D-deficient (<20 ng/mL). [Li Yupeng (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For vitamin d bone density meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Zeng Hualian (2026). The Impact of Serum 25&#8208;Hydroxyvitamin D on Bone Mineral Density at Different Skeletal Sites: A Multivariate Analysis Based on a UK Cohort Study. DOI: 10.1002/fsn3.71894. PMCID: PMC13180784. PMID: 42157955. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13180784/
• Li Yupeng (2026). Editorial: Vitamin D and aging: associations with mortality, cognition, chronic diseases, and metabolic conditions in elderly individuals. DOI: 10.3389/fendo.2026.1830429. PMCID: PMC13128371. PMID: 42077437. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13128371/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.